Back
Matinas BioPharma Holdings Stock Price Chart
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.
Sell
22
MTNB
Matinas BioPharma Holdings
Last Price:
$0.54
Seasonality Move:
13.52%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing slight buying pressure.
Matinas BioPharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.57 | Sell |
| 20-day SMA: | 0.59 | Sell |
| 50-day SMA: | 1.38 | Sell |
| 200-day SMA: | 6.37 | Sell |
| 8-day EMA: | 0.57 | Sell |
| 20-day EMA: | 0.66 | Sell |
| 50-day EMA: | 1.42 | Sell |
| 200-day EMA: | 5.65 | Sell |
Matinas BioPharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 31.02 | Sell |
| Chaikin Money Flow: | -19914 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.56 - 0.62) | Sell |
| Bollinger Bands (100): | (0.8 - 5.42) | Sell |
Matinas BioPharma Holdings Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Matinas BioPharma Holdings Stock
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 0.55 while MTNB 8-day simple moving average is 0.57, which is a Sell signal.
-
The stock price of MTNB is 0.55 while Matinas BioPharma Holdings 20-day SMA is 0.59, which makes it a Sell.
-
Matinas BioPharma Holdings 50-day simple moving average is 1.38 while MTNB share price is 0.55, making it a Sell technically.
-
MTNB stock price is 0.55 and Matinas BioPharma Holdings 200-day simple moving average is 6.37, creating a Sell signal.
MTNB Technical Analysis vs Fundamental Analysis
Sell
22
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy or a Sell?
-
Matinas BioPharma Holdings stock is rated a SellThe current Matinas BioPharma Holdings [MTNB] share price is $0.55. The Score for MTNB is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Matinas BioPharma Holdings Stock Info
Market Cap:
2.8M
Price in USD:
0.55
Share Volume:
63.4K
Matinas BioPharma Holdings 52-Week Range
52-Week High:
21.50
52-Week Low:
0.50
Sell
22
Matinas BioPharma Holdings (MTNB)
is a Sell
Matinas BioPharma Holdings Share Price Forecast
-
What is the Matinas BioPharma Holdings stock price today?The Matinas BioPharma Holdings stock price is 0.55 USD today.
-
Will MTNB stock go up or go down?Matinas BioPharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Matinas BioPharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Matinas BioPharma Holdings is overvalued.
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 0.55 while MTNB 8-day exponential moving average is 0.57, which is a Sell signal.
-
The stock price of MTNB is 0.55 while Matinas BioPharma Holdings 20-day EMA is 0.66, which makes it a Sell.
-
Matinas BioPharma Holdings 50-day exponential moving average is 1.42 while MTNB share price is 0.55, making it a Sell technically.
-
MTNB stock price is 0.55 and Matinas BioPharma Holdings 200-day simple moving average is 5.65, creating a Sell signal.
Fundamental Analysis of Matinas BioPharma Holdings
Is Matinas BioPharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.
Technical Analysis of Matinas BioPharma Holdings
Should I short Matinas BioPharma Holdings stock?
-
MTNB Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Matinas BioPharma Holdings is a Sell
-
Matinas BioPharma Holdings Relative Strength Index (RSI) is 31.02, which suggest Matinas BioPharma Holdings is oversold
-
The Bollinger Bands (25) for Matinas BioPharma Holdings is (0.56 - 0.62), which suggest Matinas BioPharma Holdings is a Sell
-
The Bollinger Bands (100) for Matinas BioPharma Holdings is (0.8 - 5.42), which suggest Matinas BioPharma Holdings is a Sell
* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.